Simpson Thacher & Bartlett is a New York-based international law firm with 900 lawyers across 11 offices across the Americas, Asia and Europe. The firm services its clients Greater China interests from its offices in Hong Kong and Beijing.
The firm is strong in private equity and is also known for equity and debt capital markets, M&A and leveraged finance.
Key clients of the firm include KKR, Softbank Group, Alibaba Group Holding, Zhongliang Holdings Group Company, Goldman Sachs, Qudian, J-Star and Aspirant Group.
During the research period, the capital markets practice kept busy advising on Hong Kong and US IPOs, follow on offerings, convertible and other bond issuances. The private equity team handled fund formation and fund raising GP/LP mandates and acquisitions for KKR and Blackstone. The corporate team was also busy with acquisitions in the healthcare, retail and automotive industries.
The firm’s capital markets practice was hit with the departures of counsels Venus Lo and David Lee in 2019.
-AG III Series Funds
-Alibaba Group Holding HKSE secondary listing
-Canaan Nasdaq IPO
-J-Star No.4 Series Funds
-KKR $1.56 billion acquisition of LCY Chemical Corp
-New Frontier Corporation $1.44 billion acquisition of United Family Healthcare
-Phoenix Tree NYSE IPO
-SoftBank $4.5 billion margin loan financing
-Weibo $800 million 3.5% bond issue
-XD HKSE IPO
Client feedback: 30th edition (2019/2020)
“Their response time is fantastic - the firm never lets you down in terms of getting a quick and efficient response whenever we needed. The response and advice is always practical and solution oriented and reflects a superior understanding of how financing transactions work.”
“Pragmatic, well-reasoned advice and understanding of the market.”
“They are highly experienced in investment funds work, and are able to distil this experience into commercially-relevant advice.”